Form 4: BioMarin Executive Charles Greg Guyer Reports Stock Disposal to Cover Tax Obligations
SEC Form 4 Filing
EVP and Chief Technical Officer of BioMarin Pharmaceutical, Charles Greg Guyer, disposed of 4,287 shares of common stock on February 28, 2025, to satisfy tax withholding obligations.
Summary
- On February 28, 2025, Charles Greg Guyer, EVP and Chief Technical Officer of BioMarin Pharmaceutical Inc., disposed of 4,287 shares of common stock.
- The transaction was executed at a price of $71.16 per share.
- The disposal was conducted to cover tax obligations related to equity awards.
- Following the transaction, Guyer directly owns 94,689 shares of BioMarin common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing indicates a routine transaction to cover tax obligations, which is a normal part of executive compensation. It doesn't necessarily reflect a positive or negative outlook on the company.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders buy or sell their company's stock. These filings are closely watched by investors for insights into management's perspective on the company's valuation and future prospects. Disposals to cover tax obligations are common and not necessarily indicative of a negative outlook.
Key Dates
| Date | Description |
|---|---|
| 02/28/2025 | Date of stock disposal transaction. |
| 03/04/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.